Dr. Erik Bogsch, Head of the Biotechnology R&D Division, Gedeon Richter
Dr. Erik Bogsch is the Head of the Biotechnology R&D Division at Gedeon Richter Plc. He is responsible for leading the R&D effort in the development of GR's biosimilar pipeline. Gedeon Richter Plc. is engaged in the development and manufacture of both bacterial cell fermentation based and mammalian cell fermentation based biosimilar products. GR has R&D, analytical & manufacturing capabilities in multiple locations in Hungary & Germany.
Dr. Bogsch, a Hungarian national, has a Natural Sciences degree from the University of Cambridge and a PhD in cell biology from the University of Warwick. Following a brief postdoctoral academic research career, he worked in the food industry for many years in R&D, Quality & Manufacturing roles in the UK, Hungary & Germany. He joined Gedeon Richter Plc. in 2012, as commissioning lead for GR's biotechnology factory in Debrecen, Hungary, before moving into his current role.
Marek Cichocki, Head of Operational R&D, Polpharma
Marek Cichocki has been working in pharmaceutical industry for 13 years. He is an R&D expert with special focus on solid oral dosage forms development and manufacturing. Marek’s professional specialization includes: formulation design, scale-up and technology transfer activities, process validation, and new manufacturing methods.
Marek started his career in 2005 in Pliva Kraków (Poland) where he was a Formulation Scientist. From the beginning of 2010 Marek spent almost 4 years at Synthon BV (The Netherlands) being responsible for the implementation of newly developed products at Contract Manufacturing Organisations. In February 2014 Marek joined Polpharma (Poland) and became Head of Formulation Development team. Currently he is holding a position of Head of Operational R&D and his main responsibilities are: post-approval product maintenance, technology transfers, R&D support for industrial operations and new technologies implementation.
Christopher Hunley, Site Director, GSK Biologicals Kft.
Chris is the Site Director at the GSK Biologicals Kft. Vaccine manufacturing facility in Gödöllő. He joined the site in 2015, after 5 years working in Italy and Germany with Novartis Vaccines. Before moving into the vaccines business, he spent several years working for Amgen in the United States on the manufacturing of various bulk biologics. Chris is a chemical engineer, who has spent his career working in manufacturing facilities with roles in Manufacturing, Validation, Project Management, and Manufacturing Sciences & Technology.
Dr. Piotr Lipiński, Quality Systems Manager/QP, Novartis Technical Operations-Platform Solids Europe, Lek / Novartis
Piotr has over 10 years of experience in pharmaceutical companies. Currently he is Quality Systems Manager and Qualified Person in Novartis Technical Operation in Poland.
The experience includes particularly scope quality systems implementation, self-inspections, trainings and auditing of materials, products suppliers and service providers. Piotr has detailed knowledge in scope of all GxP rules with special focus on Good Manufacturing Practice and Good Distribution Practice.
Piotr is a PhD. Eng. in scope of Technology of Chemistry. Additionally, he completed post-graduate studies in scope of Industrial Chemistry at Medical University of Gdansk. He was participating as well in numerous courses related to GMP aspects in pharmaceutical industry.
Dr. Tomáš Groh, Part of the Biotechnology R&D Division, Bioinova
Tomáš works at the Biotechnology R&D Division at Bioinova, Ltd., a company based in Prague, Czech Republic. He is responsible for early as well as late stages of new products development. Several key ideas arisen from his activities have already been patented. As for pharmaceutical industry, Tomáš has extensive experience in Quality Control (QC) Environment. He established new lab within Bioinova´s QC department, primarily performing flow cytometry and nucleic acid amplification techniques. Tomáš, a Czech national, has a Natural Sciences degree from Charles University in Prague. He obtained his PhD in Biochemistry during his work at the Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital.
Dr. Zsolt Holló, Head of the Center of Biological Business Development and Technology, EGIS
Dr. Holló is medical doctor by training, obtained his PhD in cellular physiology at Semmelweis University (Budapest) and MBA degree at the Budapest University of Technology and Economics. Dr. Holló has over 10 years experience in biotechnology. Currently he is Head of the Biological Business Development and Technology Center at EGIS Pharmaceuticals Plc. His major responsibilities include biosimilar product-candidate evaluations; the implementation of biosimilar product related manufacturing and analytical technologies, quality control, management of technology transfers; developing partnerships in these areas. Prior to this position he was Chief Operations Officer at Solvo Biotechnology. He has spent more than 5 years in molecular diagnostics, in various positions from laboratory head to CEO. He has worked in the Netherlands Cancer Institute as an EMBO postdoctoral fellowship holder. Dr. Hollo has several publications and patents in cellular signalling, multidrug resistance and molecular diagnostics.
Lenka Francišković, Head of Processes and Products Quality, Belupo Pharmaceuticals
Lenka is a Pharmaceutical Professional with a unique combination of pharmaceutical management experience and exceptional knowledge in the areas of the New Product Evaluation, Laboratory Operations, Pharmaceutical Analysis and Project Management. She has an extensive experience in pharmaceutical industry in Research and Development, Regulatory Affairs, Quality Assurance and Quality Control Environment as well as profound knowledge of TPB and FDA, EU and Croatian regulatory submission requirements. Strong knowledge of GMP, GLP, ICH guidelines and Pharmacopoeia is inevitable part of Lenkas‘ professional skills. Lenka is currently Head of Processes and Products Quality for Belupo Pharmaceuticals Croatia. Prior to this work, she worked in several positions at Apotex Inc. Toronto, Ontario and Genpharm Inc. (now Milan Pharmaceuticals) in Etobicoke, Ontario. Lenka has published several publications, is member of Pharmaceutical Sciences Group, Toronto and Croatian Association for Quality.
Grzegorz Brzoskowski, Security Director CEE / Baltic, SANOFI
Grzegorz Brzoskowski started his career at the National Police in Poland. Between 2007 and 2012 he was working as the Senior Security Partner at Genzyme Europe, Middle East and Africa (EMEA) and since 2012 Grzegorz Brzoskowski is in his current position as Regional Security Director Central East Europe at SANOFI responsible for 17 countries.
Dr. András Ballagi, CTO, Diagon
Dr. Ballagi moved to Sweden shortly after completing his degree in Bioengineering. There he worked in the field of the diagnosis and molecular evolution of veterinary viruses at the Swedish Veterinary Institute. He received his PhD for his research on application of PCR for virus detection and analysis of viral outbreaks. Later he moved on to fermentation technology of recombinant microorganisms at the University of Uppsala. After almost 20 years in Sweden he returned to Hungary in 2006 and joined Gedeon Richter Plc. to lead the technology development for biosimilar medicine production using bacteria (E.coli) as well as mammalian (CHO) cells.
In 2014 he formed the Biotechnology unit in the newly established Pharmatech Model Laboratory (PML) at the Budapest University of Technology and Economics, where he is also holding an Honorary Professorship. Since November 2016 he responsible for the recombinant protein development and production of human diagnostic at the Diagon Ltd, Budapest.